Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic Arthritis

September 18, 2020 updated by: Melissa Köprülüoğlu
The purpose of this study is to assess hand functions and wrist joint position sense in patients with and without PsA.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In this study, 54 patients (18 of them RA, 18 of them PsA and, 18 of them asymptomatic healthy group) were included. The patient group was selected from the patients who came to the Izmir Katip Celebi University Ataturk Training and Research Hospital Rheumatology Outpatient Clinic for routine control.

Participants were matched according to age and gender. It was recorded demographic and clinical data.

Grip and pinch strengths were evaluated within the scope of hand function evaluation. Wrist joint position sense was evaluated along with hand functions.

Study Type

Observational

Enrollment (Actual)

54

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Izmir/ Cigli
      • Izmir, Izmir/ Cigli, Turkey
        • Izmir Katip Celebi University Ataturk Research and Training Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

54 participants

  • 18 of them PsA
  • 18 of them RA
  • 18 of them asymptomatic healthy group

Description

Inclusion Criteria:

  • to be diagnosed according to CASPAR or ACR/ EULAR 2010 criteria for patient groups
  • taking regular medication for patient groups,
  • have complaints related to hand / wrist joints for patients groups,
  • have no complaints related to upper extremity for asymptomatic healthy group.
  • have any rheumatologic disease and OA diagnosed according to traditional criteria

Exclusion Criteria:

  • finger infection and / or finger amputation,
  • using orthoses,
  • to report a diagnosis of neurological disease,
  • to report a history of trauma or surgery involving the upper extremity,
  • to report a psychiatric and / or cognitive problem

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Psoriatic Arthritis
Patients diagnosed with PsA according to CASPAR criteria by the rheumatologist were included.
Other: This study does not contain any intervention.
This study does not contain any intervention.
Rheumatoid Arthritis
Patients diagnosed with RA according to ACR / EULAR 2010 criteria by the rheumatologist were included.
Other: This study does not contain any intervention.
This study does not contain any intervention.
Asymptomatic Healthy Group
Participants had any neurological and/or rheumatological diseases, no complaints about the upper extremity. Participants diagnosed with OA according to traditional clinical criteria were excluded from the study.
Other: This study does not contain any intervention.
This study does not contain any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grip Strength
Time Frame: Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Grip strenght was examined using a hand dynamometer (Lafayette Proffessional Hand Held Dynamometer, USA).
Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Two-Point Pinch Strength
Time Frame: Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
It was evaluated by pinchmeter (Lafayette,USA).
Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Three-Point Pinch Strength
Time Frame: Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
It was evaluated by pinchmeter (Lafayette,USA).
Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Lateral Pinch Strength
Time Frame: Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
It was evaluated by pinchmeter (Lafayette,USA).
Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
DASH score
Time Frame: Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
The DASH score provides information about the general functionality of the upper extremity and especially activities of hand.
Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Wrist Joint Position Sense
Time Frame: Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Wrist joint position sense was evaluated by goniometric re-position error test ( in 30◦ wrist extansion, 3 repeat ).
Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Melissa Köprülüoğlu

Investigators

  • Principal Investigator: İlknur NAZ GÜRŞAN, PhD, İzmir Katip Celebi University, Faculty of Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

June 1, 2020

Study Completion (Actual)

August 30, 2020

Study Registration Dates

First Submitted

September 5, 2020

First Submitted That Met QC Criteria

September 11, 2020

First Posted (Actual)

September 17, 2020

Study Record Updates

Last Update Posted (Actual)

September 22, 2020

Last Update Submitted That Met QC Criteria

September 18, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Izmir Katip Celebi University

Plan for Individual participant data (IPD)

Study Data/Documents

  1. Clinical Study Report

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psoriatic Arthritis

Clinical Trials on This study does not contain any intervention.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe